Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 11.8 to 8.8.
Financials
Financial year 2025
VAN ROOIJEN PHARMA from Turnhout, company number BE0478869796, closed financial year 2025 with a result of € 473,826 after tax. For that financial year VAN ROOIJEN PHARMA recorded revenue of € 4.1 million and equity of € 669,200. Compared with financial year 2024, the result moved from € 353,886 to € 473,826. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 669,200
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 473,826
▲ 34% vs 2024
Profit after tax over the fiscal year.
€ 400,000 paid out
84 % of the profit went to the shareholders, mostly to VAN ROOIJEN BEHEER BELGIE (100 % of the shares). That is where the money ends up.
People and assets in 2025
8.8
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 570,937
▲ 8% vs 2024
€ 64,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 35,696
▲ 4% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 448,863
▲ 27% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 52 days on average.
€ 165,574
▲ 73% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 3,595,663 | € 3,516,167 | € 3,519,036 | € 4,111,289 | ▲ 17% |
| Profit after taxes | € 112,530 | € 312,367 | € 353,886 | € 473,826 | ▲ 34% |
| Equity | € 379,121 | € 491,488 | € 595,374 | € 669,200 | ▲ 12% |
| Total debts | € 1,009,885 | € 830,856 | € 857,372 | € 1,016,537 | ▲ 19% |
| Retained profit | € 317,121 | € 429,488 | € 533,374 | € 607,200 | ▲ 14% |
| Dividend | € 100,000 | € 200,000 | € 250,000 | € 400,000 | ▲ 60% |
| Balance sheet total | € 1,389,006 | € 1,322,344 | € 1,452,746 | € 1,685,737 | ▲ 16% |
| Employees (FTE) | 13.9 | 11.8 | 8.9 | 8.8 | ▼ 0.1 |
Key figures of VAN ROOIJEN PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to VAN ROOIJEN PHARMA?
What happened at VAN ROOIJEN PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- VAN ROOIJEN HOLDING BV stepped down as director. NBB
- Michaël van Rooijen stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 473,826 (▲ 34% vs 2024). Source: NBB ↗
- VAN ROOIJEN HOLDING BV became a director. NBB
- Michaël van Rooijen became a director. NBB
- New establishment in Turnhout. KBO
- New establishment in Turnhout. KBO
- Start of the company according to the CBE. KBO
In short
From € 112,530 profit in 2022 to € 473,826 profit in 2025.
Paid € 428,040 in corporate taxes since 2022.
Best year ever: 2025, with € 473,826 profit.
Paid out € 950,000 in dividends to the owners in total.
Management
The stake of VAN ROOIJEN BEHEER BELGIE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
VAN ROOIJEN PHARMAThe shares are held by VAN ROOIJEN BEHEER BELGIE (100%).
Directors
According to the 2025 annual accounts
Gedelegeerd bestuurder · represented by Henricus van Rooijen
Also active at: VAN ROOIJEN BEHEER BELGIE, VAN ROOIJEN LOGISTIEK
since 2023 · until 2029
Michaël van Rooijen
Bestuurder
Also active at: VAN ROOIJEN BEHEER BELGIE, MF VAN ROOIJEN MANAGEMENT, RUBENCO, VAN ROOIJEN HOLDING, VAN ROOIJEN LOGISTIEK, VAN ROOIJEN IMMO, van Rooijen Immo Holding, van Rooijen Immo II +2 more
since 2023 · until 2029
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Schietstandlaan 2
2300 Turnhout
Industriedijk 15
2300 Turnhout
Active since 1 April 2018
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →VAN ROOIJEN BEHEER BELGIE same network
€ 2 million revenue · 2025
VAN ROOIJEN HOLDING same network
€ 402,863 revenue · 2025
VAN ROOIJEN LOGISTIEK same network
€ 35.8 million revenue · 2025
VAN ROOIJEN IMMO same network
€ 1.8 million gross margin · 2025
van Rooijen Immo Holding same network
€ 361,482 gross margin · 2025
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0478.869.796
- VAT number
- BE 0478.869.796
- Registered office
- Schietstandlaan 2, 2300 Turnhout
- Names & denominations
- VAN ROOIJEN PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 November 2002
- Peppol
- Active · Active since 29 Dec 2025
- Activities · NACE
Opslag
Overige opslag